Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

PMS-SULFASALAZINE E.C.TABLET 500 MG - HSA Drug Approval Details

Approvals/HSA/PMS-SULFASALAZINE E.C.TABLET 500 MG

Approved

THERAPEUTIC

PMS-SULFASALAZINE E.C.TABLET 500 MG

DRAGENOPHARM APTHEKER PUSHL GMBH & CO (GERMANY)🇸🇬 Health Sciences Authority

Approval Date: Aug 19, 1991
Approval ID: f16fa99e4b282b3a
Company: DRAGENOPHARM APTHEKER PUSHL GMBH & CO (GERMANY)
Type: Therapeutic

Approval Details

Approval Id: f16fa99e4b282b3a
Drug Name: PMS-SULFASALAZINE E.C.TABLET 500 MG
Product Name: PMS-SULFASALAZINE E.C.TABLET 500 MG
Approval Number: SIN06512P
Approval Date: 1991-08-19
Registrant: SYNMOSA BIOPHARMA PTE. LTD.
Licence Holder: SYNMOSA BIOPHARMA PTE. LTD.
Drug Type: Therapeutic
Forensic Classification: PRESCRIPTION ONLY MEDICINES
Dosage Form: ENTERIC COATED TABLET
Route Of Administration: ORAL
Atc Code: A07EC01
Atc Item Name: sulfasalazine
Pharma Manufacturer Name: MEDICELL PHARMACEUTICAL (S) PTE. LTD.

Active Ingredients

SULFASALAZINE

500 mg

SULFASALAZINE

500 MG

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Aug 19, 1991

Approval ID

f16fa99e4b282b3a

Type

Therapeutic

Back to HSA Approvals